Katsumi Kozasa

Katsumi Kozasa

Auto-generated profile, based on publicly available information

Katsumi Kozasa

Department of Obstetrics and Gynecology, Kaizuka City Hospital, Osaka, Japan

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
EYEriko Yokoi
Eriko Yokoi
SMSeiji Mabuchi
Seiji Mabuchi
RTRyoko Takahashi
Ryoko Takahashi
YMYuri Matsumoto
Yuri Matsumoto
HKHiromasa Kuroda
Hiromasa Kuroda
TKTadashi Kimura
Tadashi Kimura
Yokoi E, et al. J Gynecol Oncol. 2016 Aug;28:e19. https://doi.org/10.3802/jgo.2017.28.e19

14 August 2018 in Clinical Cancer Research
Verified
Journal Article
Closed access
PDF file
TSTomoyuki Sasano
Tomoyuki Sasano
SMSeiji Mabuchi
Seiji Mabuchi
KKKatsumi Kozasa
Katsumi Kozasa
HKHiromasa Kuroda
Hiromasa Kuroda
MKMahiru Kawano
Mahiru Kawano
TKTadashi Kimura
Tadashi Kimura
Purpose: The aim of this study was to investigate the metastatic potential of uterine cervical and endometrial cancer displaying tumor-related leukocytosis (TRL). Experimental Design: Clinical data on uterine cervical (N = 732) and endometrial cancer (N = 900) were collected, and the metastatic potential of TRL-positive cancer was evaluated in univariate and multivariate analyses. Tumor and blood samples obtained from patients with cervical cancer, cervical cancer cell lines, and a mouse model of cervical cancer were used to examine the mechanisms underlying the highly metastatic nature of TRL-positive cancer, focusing on tumor-derived G-CSF and the myeloid-derived suppressor cell (MDSC)-mediated premetastatic niche. Results: Pretreatment TRL was significantly associated with visceral organ metastasis in patients with uterine cervical or endometrial cancer. The patients with TRL-positive cervical cancer displayed upregulated tumor G-CSF expression, elevated G-CSF levels, and increased MDSC frequencies in the peripheral blood compared with the TRL-negative patients. In vitro and in vivo investigations revealed that MDSCs produced in response to tumor-derived G-CSF are involved in premetastatic niche formation, which promotes visceral organ metastasis of TRL-positive cancer. The depletion of MDSCs attenuated this premetastatic niche formation and effectively inhibited the visceral organ metastasis of TRL-positive cancer. Conclusions: Uterine cervical/endometrial cancer displaying TRL is a distinct clinical entity with high metastatic potential. Tumor-derived G-CSF and the MDSC-mediated premetastatic niche are responsible for the highly metastatic nature of this type of cancer. MDSC-targeting therapy might represent a potential strategy for combating metastasis derived from TRL-positive uterine cancer. Clin Cancer Res; 24(16); 4018–29. ©2018 AACR.

25 August 2015 in Radiation Oncology
Verified
Journal Article
Open access
PDF file
FIFumiaki Isohashi
Fumiaki Isohashi
SMSeiji Mabuchi
Seiji Mabuchi
YYYasuo Yoshioka
Yasuo Yoshioka
YSYuji Seo
Yuji Seo
OSOsamu Suzuki
Osamu Suzuki
KOKazuhiko Ogawa
Kazuhiko Ogawa
The purpose of this study is to report our clinical outcomes using intensity-modulated radiation therapy (IMRT) for adjuvant treatment of cervical cancer, compared with three-dimensional conformal radiation therapy (3DCRT), in terms of tumor control, complications and dose-volume histogram (DVH) parameters. Between March 2008 and February 2014, 62 patients were treated with concurrent nedaplatin-based chemotherapy and whole-pelvic external beam radiation therapy (RT). Of these patients, 32 (52 %) received 3DCRT and 30 (48 %) received IMRT. The median follow-up periods were 40 months (range 2–74 months). The 3-year overall survival rate (OS), locoregional control rate (LRC) and progression-free survival rate (PFS) were 92, 95 and 92 % in the IMRT group, and 85, 82 and 70 % in the 3DCRT group, respectively. A comparison of OS, LRC and PFS showed no significant differences between IMRT and 3DCRT. The 3-year cumulative incidences of grade 2 or higher chronic gastrointestinal (GI) complications were significantly lower with IMRT compared to 3DCRT (3 % vs. 45 %, p < .02) and in patients with V40 of the small bowel loops of ≤340 mL compared to those with >340 mL (3 % vs. 45 %, p < .001). Patients treated with IMRT had a higher incidence of grade 3 acute hematologic complications (p < .05). V40 and V45 of the small bowel loops or bowel bag were predictive for development of both acute and chronic GI complications. Our results suggest that IMRT for adjuvant treatment of cervical cancer is useful for decreasing GI complications without worsening outcomes.

1 December 2020 in Journal of Surgical Case Reports
Verified
Journal Article
Open access
PDF file
KKKatsumi Kozasa
Katsumi Kozasa
YTYuki Takemoto
Yuki Takemoto
TGTakeshi Goto
Takeshi Goto
MKMariya Kobayashi
Mariya Kobayashi
HSHitomi Sakaguchi
Hitomi Sakaguchi
TYTakeshi Yokoi
Takeshi Yokoi
Peritoneal inclusion cysts (PICs) often develop in post-operative patients. Since the incidence of adhesions is lower with laparoscopic surgery than with open surgery, PICs are less likely to occur in the former. Although post-operative adhesions or PICs rarely develop after laparoscopic surgery (such as total laparoscopic hysterectomy: TLH), we encountered two cases of giant PICs with abdominal pain after TLH. In Case 1, strong adhesion was already present when TLH was performed. Therefore, this case may have been predisposed to the development of adhesions in the abdominal cavity. However, no adhesions were observed during TLH in case 2, and there were no risk factors, such as pre-operative adhesions and endometriosis. Therefore, adhesions and PICs may develop even after TLH, and approaches need to be considered for their prevention.

31 March 2023
Verified
Other
Open access
TSTomoyuki Sasano
Tomoyuki Sasano
SMSeiji Mabuchi
Seiji Mabuchi
KKKatsumi Kozasa
Katsumi Kozasa
HKHiromasa Kuroda
Hiromasa Kuroda
MKMahiru Kawano
Mahiru Kawano
TKTadashi Kimura
Tadashi Kimura
Expression of G-CSF and existence of MDSC in TRL-positive cervical cancer/endometrial cancer.

31 March 2023
Verified
Other
Open access
TSTomoyuki Sasano
Tomoyuki Sasano
SMSeiji Mabuchi
Seiji Mabuchi
KKKatsumi Kozasa
Katsumi Kozasa
HKHiromasa Kuroda
Hiromasa Kuroda
MKMahiru Kawano
Mahiru Kawano
TKTadashi Kimura
Tadashi Kimura